Risk of functional impairment in Facioscapulohumeral muscular dystrophy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risk of functional impairment in Facioscapulohumeral muscular dystrophy

Published:2014-02-10 Issue:4 Volume:49 Page:520-527
ISSN:0148-639X
Container-title:Muscle & Nerve
language:en
Short-container-title:Muscle Nerve

Author:

Statland Jeffrey M.¹,Tawil Rabi¹

Affiliation:

1. Department of Neurology; University of Rochester Medical Center; 265 Crittenden Boulevard, CU 420669 Rochester New York 14642-0669 USA

Publisher

Wiley

Subject

Physiology (medical),Cellular and Molecular Neuroscience,Clinical Neurology,Physiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mus.23949/fullpdf

Reference31 articles.

1. Genetic characterization of a large, historically significant Utah kindred with facioscapulohumeral dystrophy;Flanigan;Neuromuscul Disord,2001

2. Facioscapulohumeral muscular dystrophy: epidemiological and molecular study in a north-east Italian population sample;Mostacciuolo;Clin Genet,2009

3. Patient identified disease burden in fascioscapulohumeral muscular dystrophy;Johnson;Muscle and Nerve,2012

4. A standardized clinical evaluation of patients affected by facioscapulohumeral muscular dystrophy: the FSHD clinical score;Lamperti;Muscle Nerve,2010

5. Correlation between fragment size at D4F104S1 and age at onset or at wheelchair use, with a possible generational effect, accounts for much phenotypic variation in 4q35-facioscapulohumeral muscular dystrophy (FSHD);Lunt;Hum Mol Genet,1995

Cited by 79 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An open-label pilot study of losmapimod to evaluate the safety, tolerability, and changes in biomarker and clinical outcome assessments in participants with facioscapulohumeral muscular dystrophy type 1;Journal of the Neurological Sciences;2024-07

2. Recognizing Myopathy in Patients with Muscle Weakness or Pain;Primary Care: Clinics in Office Practice;2024-06

3. Clinical Application of Optical Genome Mapping for Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy;Annals of Laboratory Medicine;2024-05-10

4. Safety and efficacy of losmapimod in facioscapulohumeral muscular dystrophy (ReDUX4): a randomised, double-blind, placebo-controlled phase 2b trial;The Lancet Neurology;2024-05

5. Treatment Approaches for Altered Facial Expression: A Systematic Review in Facioscapulohumeral Muscular Dystrophy and Other Neurological Diseases;Journal of Neuromuscular Diseases;2024-04-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3